H

Hospital Universitario Virgen Macarena | Hematology Department

Research site
(Unclaimed)
Location
3 Avenida Doctor Fedriani, Sevilla, Sevilla, Spain

Site insights

Top conditions

Top treatments

Bevacizumab
ABBV-400

Parent organization

This site is a part of Hospital Universitario Virgen Macarena

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 2 total trials

Study to Assess Adverse Events and Change in Disease Activity in Adult Participants With Advanced Solid Tumors Receiving Intravenous (IV) ABBV-400 as Monotherapy and in Combination With IV Bevacizumab

Cancer is a condition where cells in a specific part of body grow and reproduce uncontrollably. The purpose of this study is to assess adverse events...

Enrolling
Gastroesophageal Adenocarcinoma
Advanced Solid Tumors
Drug: ABBV-400
Drug: Trifluridine/Tipiracil

Trial sponsors

AbbVie logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems